CJC-1295 with DAC
Long-acting GHRH analogue with Drug Affinity Complex technology that binds albumin for a half-life of 6-8 days, sustaining elevated GH and IGF-1 for continuous
Buy more, save more
Total Price
$85
For research & laboratory use only. Not for human consumption.
Half-Life
6-8 days
Administration Route
Subcutaneous injection
7-Day Active Window
Drug Affinity Complex extends GHRH half-life dramatically
Weekly Dosing Protocol
Once-weekly injection achieves sustained GH elevation
GHRH Amplification
Synergises with GHRP for 10x GH output vs GHRP alone
Effect Profile
Muscle Growth
Fat Oxidation
Recovery Speed
Strength
Mechanism of Action
Scientific Research
J Clin Endocrinol Metab (2006)
J Clin Endocrinol Metab (2006)
Product FAQs
Stacks Well With
Ipamorelin
Highly selective growth hormone secretagogue with minimal cortisol or prolactin stimulation, offering clean GH pulses for muscle growth, recovery, and body
GHRP-2
Second-generation GHRP with potent GH-releasing activity and mild ghrelin-like effects on appetite, studied for GH deficiency, muscle preservation, and
CJC-1295 + Ipamorelin Combo
The gold-standard GH secretagogue combination - CJC-1295 (GHRH receptor) and Ipamorelin (ghrelin receptor) producing synergistic, pulsatile GH release 3-5x
Related Products
CJC-1295 without DAC
Modified GHRH fragment (Mod GRF 1-29) that produces acute, physiological GH pulses when combined with a GHRP. The standard pairing with ipamorelin for clean GH
Ipamorelin
Highly selective growth hormone secretagogue with minimal cortisol or prolactin stimulation, offering clean GH pulses for muscle growth, recovery, and body
Sermorelin
Native GHRH(1-29) fragment that has the most clinical history of all GHRH peptides. Studied extensively for age-related GH decline and HPA axis normalisation.
Tesamorelin
FDA-approved GHRH analogue (Egrifta) for HIV-associated visceral fat reduction. The most clinically validated GHRH peptide for abdominal fat mobilisation and